Skip to main content

Advertisement

SpringerLink
Log in

A Patient with Novel ICOS Mutation Presented with Progressive Loss of B Cells

  • Letter to Editor
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, Anagnostopoulos I, et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature. 1999;397(6716):263–6.

    Article  CAS  Google Scholar 

  2. Schepp J, Chou J, Skrabl-Baumgartner A, Arkwright PD, Engelhardt KR, Hambleton S, et al. 14 years after discovery: clinical follow-up on 15 patients with inducible co-stimulator deficiency. Front Immunol. 2017;8:964.

    Article  Google Scholar 

  3. Abolhassani H, El-Sherbiny YM, Arumugakani G, Carter C, Richards S, Lawless D, et al. Expanding clinical phenotype and novel insights into the pathogenesis of ICOS deficiency. J Clin Immunol. 2020;40(2):277–88.

    Article  CAS  Google Scholar 

  4. Takahashi N, Matsumoto K, Saito H, Nanki T, Miyasaka N, Kobata T, et al. Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients. J Immunol. 2009;182(9):5515–27.

    Article  CAS  Google Scholar 

  5. Bousfiha A, Jeddane L, Picard C, Al-Herz W, Ailal F, Chatila T, et al. Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification. J Clin Immunol. 2020;40(1):66–81.

    Article  Google Scholar 

  6. Chou J, Massaad MJ, Cangemi B, Bainter W, Platt C, Badran YR, et al. A novel mutation in ICOS presenting as hypogammaglobulinemia with susceptibility to opportunistic pathogens. J Allergy Clin Immunol. 2015;136(3):794–7 e1.

    Article  CAS  Google Scholar 

  7. Robertson N, Engelhardt KR, Morgan NV, Barge D, Cant AJ, Hughes SM, et al. Astute clinician report: a novel 10 bp frameshift deletion in exon 2 of ICOS causes a combined immunodeficiency associated with an enteritis and hepatitis. J Clin Immunol. 2015;35(7):598–603.

    Article  CAS  Google Scholar 

  8. Salzer U, Maul-Pavicic A, Cunningham-Rundles C, Urschel S, Belohradsky BH, Litzman J, et al. ICOS deficiency in patients with common variable immunodeficiency. Clin Immunol. 2004;113(3):234–40.

    Article  CAS  Google Scholar 

  9. Grimbacher B, Hutloff A, Schlesier M, Glocker E, Warnatz K, Drager R, et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol. 2003;4(3):261–8.

    Article  CAS  Google Scholar 

  10. Garcia-Prat M, Alvarez-Sierra D, Aguilo-Cucurull A, Salgado-Perandres S, Briongos-Sebastian S, Franco-Jarava C, et al. Extended immunophenotyping reference values in a healthy pediatric population. Cytometry B Clin Cytom. 2019;96(3):223–33.

    Article  CAS  Google Scholar 

  11. Kiykim A, Ogulur I, Dursun E, Charbonnier LM, Nain E, Cekic S, et al. Abatacept as a long-term targeted therapy for LRBA deficiency. J Allergy Clin Immunol Pract. 2019;7(8):2790–800 e15.

    Article  Google Scholar 

Download references

Funding

This work was supported by the Scientific and Technological Research Council of Turkey to S.B. (318S202).

Author information

Authors and Affiliations

  1. School of Medicine, Division of Pediatric Allergy and Immunology, Marmara University, Fevzi Çakmak Mah. No: 41, Pendik, Istanbul, Turkey

    Asena Pınar Sefer, Nurhan Kasap, Bengu Akcam, Sevgi Bilgic Eltan, Ahmet Ozen, Elif Karakoc-Aydiner & Safa Baris

  2. Istanbul Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Istanbul, Turkey

    Asena Pınar Sefer, Nurhan Kasap, Bengu Akcam, Sevgi Bilgic Eltan, Ahmet Ozen, Elif Karakoc-Aydiner & Safa Baris

  3. The Isil Berat Barlan Center for Translational Medicine, Istanbul, Turkey

    Asena Pınar Sefer, Nurhan Kasap, Bengu Akcam, Sevgi Bilgic Eltan, Ahmet Ozen, Elif Karakoc-Aydiner & Safa Baris

  4. Division of Immunology, Boston Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA

    Louis Marie Charbonnier

  5. Umraniye Education and Research Hospital, Department of Pediatric Genetics, Health Science University, Istanbul, Turkey

    Yasemin Kendir Demirkol

Authors
  1. Asena Pınar Sefer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Louis Marie Charbonnier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nurhan Kasap
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bengu Akcam
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yasemin Kendir Demirkol
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sevgi Bilgic Eltan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ahmet Ozen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Elif Karakoc-Aydiner
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Safa Baris
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Safa Baris.

Ethics declarations

The study was approved by the local ethics committee of Marmara University and written informed consents were obtained from the patient and her parents.

Conflict of Interest

Authors declare no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic Supplementary Material

ESM 1

(DOCX 21.6 kb)

ESM 2

(XLSX 53 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sefer, A.P., Charbonnier, L.M., Kasap, N. et al. A Patient with Novel ICOS Mutation Presented with Progressive Loss of B Cells. J Clin Immunol 41, 251–255 (2021). https://doi.org/10.1007/s10875-020-00889-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-020-00889-1

Search

Navigation